ES2077514B1 - Composicion farmaceutica topica para el tratamiento de alergias respiratorias. - Google Patents

Composicion farmaceutica topica para el tratamiento de alergias respiratorias.

Info

Publication number
ES2077514B1
ES2077514B1 ES09302407A ES9302407A ES2077514B1 ES 2077514 B1 ES2077514 B1 ES 2077514B1 ES 09302407 A ES09302407 A ES 09302407A ES 9302407 A ES9302407 A ES 9302407A ES 2077514 B1 ES2077514 B1 ES 2077514B1
Authority
ES
Spain
Prior art keywords
treatment
respiratory allergies
pharmaceutical composition
composition
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES09302407A
Other languages
English (en)
Other versions
ES2077514A1 (es
Inventor
Giuliano Molinari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmin Srl
Original Assignee
Farmin Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmin Srl filed Critical Farmin Srl
Publication of ES2077514A1 publication Critical patent/ES2077514A1/es
Application granted granted Critical
Publication of ES2077514B1 publication Critical patent/ES2077514B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICION FARMACEUTICA TOPICA DE UTLIDAD EN EL TRATAMIENTO DE ALERGIAS RESPIRATORIAS QUE CONTIENE COMO AGENTE ACTIVO, AL MENOS UN COMPUESTO ORGANICO O INORGANICO, DE PESO MOLECULAR INFERIOR A 350 D Y CAPAZ DE FORMAR UN COMPLEJO CON CALCIO Y QUE CONTIENE UNO O MAS ACIDOS CONSTITUYENTES NORMALES DEL ORGANISMO HUMANO O SUS SUSTITUTOS ANALOGOS QUE CONTIENEN UNO O MAS GRUPOS AÑADIDOS DE TIPOS AQUIL-, ARIL-, AXIL-, OXO-, ALCOXI-, HIDROXI-, AMINO Y SUS DERIVADOS FUNCIONALES DEL TIPO DE LOS ANHIDRIDOS, LACTONAS, LACTIDAS Y SUS RESPECTIVAS SALES, CUYA COMPOSICION ESTA PRESENTADA EN LAS FORMAS DE SOLUCION O SUSPENSION PARA INSTILACION, INHALACION O INSUFLACION, CON LIBERACION CONTROLADA DEL AGENTE ACTIVO. ESTA COMPOSICION ES APLICABLE EN EL TRATAMIENTO DE ALERGIAS RESPIRATORIAS.
ES09302407A 1992-11-18 1993-11-17 Composicion farmaceutica topica para el tratamiento de alergias respiratorias. Expired - Lifetime ES2077514B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT92BS000130A IT1265647B1 (it) 1992-11-18 1992-11-18 Composizione farmaceutiche topiche per le allergie respiratorie

Publications (2)

Publication Number Publication Date
ES2077514A1 ES2077514A1 (es) 1995-11-16
ES2077514B1 true ES2077514B1 (es) 1996-08-01

Family

ID=11344968

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09302407A Expired - Lifetime ES2077514B1 (es) 1992-11-18 1993-11-17 Composicion farmaceutica topica para el tratamiento de alergias respiratorias.

Country Status (9)

Country Link
US (1) US5547946A (es)
JP (1) JPH072697A (es)
AU (1) AU5070493A (es)
CA (1) CA2103294A1 (es)
DE (1) DE4339144A1 (es)
ES (1) ES2077514B1 (es)
FR (1) FR2698544B1 (es)
GB (1) GB2273045A (es)
IT (1) IT1265647B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1282733B1 (it) 1996-05-20 1998-03-31 Flarer S A Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
US20030105162A1 (en) * 2001-08-21 2003-06-05 Celluar Sciences, Inc. Method for treating bronchial constriction and bronchospasm
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US9358242B2 (en) 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
IL52045A (en) * 1976-08-25 1979-12-30 Mundipharma Ag Sprayable germicidal foam compositions
US4097596A (en) * 1976-11-02 1978-06-27 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
JPH0625068B2 (ja) * 1982-12-10 1994-04-06 シンテツクス（ユ−・エス・エ−・）インコ−ポレイテイド 鼻腔内投与用組成物及びその製造方法
DE3409403A1 (de) * 1984-03-14 1985-09-26 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Lipoxygenasehemmendes arzneimittel
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
DE3546165A1 (de) * 1985-12-27 1987-10-15 Madaus & Co Dr Verwendung von azoniaspironortropanolestern als asthmatherapeutikum und als broncholytikum
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
US5126432A (en) * 1988-02-12 1992-06-30 Miles Inc. Calcium channel modulating substances
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
US5202130A (en) * 1989-08-31 1993-04-13 The Johns Hopkins University Suppression of eczematous dermatitis by calcium transport inhibition
CS277464B6 (en) * 1989-09-26 1993-03-17 Ustav Makromolekularni Chemie Contact lens made of hydrophilic gels
IT1239474B (it) * 1989-10-27 1993-11-02 Depha Team Srl Composizioni farmaceutiche a base di l-alfa-glicerofosforil-d-myo- inositolo o suoi sali alcalini o alcalino-terrosi per la terapia delleneuropatie periferiche di origine dismetabolica o tossica, e delle cerebropatie su base organica e funzionale
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
IT1238683B (it) * 1990-02-09 1993-09-01 Istituto Chemioterapico Procedimento di preparazione di l-a-glicerilfosforil-d-myoinositolo e suoi sali da fosfatidi grezzi o parzialmente purificati
GB9013543D0 (en) * 1990-06-18 1990-08-08 Beecham Group Plc Novel products
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
IT1254991B (it) * 1992-06-24 1995-10-11 Chemi Spa Procedimento per la preparazione di glicerofosfolipidi
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery

Also Published As

Publication number Publication date
ES2077514A1 (es) 1995-11-16
GB2273045A (en) 1994-06-08
ITBS920130A1 (it) 1994-05-18
CA2103294A1 (en) 1994-05-19
DE4339144A1 (de) 1994-05-26
ITBS920130A0 (it) 1992-11-18
FR2698544B1 (fr) 1995-12-22
JPH072697A (ja) 1995-01-06
FR2698544A1 (fr) 1994-06-03
US5547946A (en) 1996-08-20
GB9323104D0 (en) 1994-01-05
AU5070493A (en) 1994-06-02
IT1265647B1 (it) 1996-11-22

Similar Documents

Publication Publication Date Title
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2114620T3 (es) Composiciones antitumorales que contienen derivados del taxano.
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
ES2151906T3 (es) Utilizacion de envolventes de bacterias del orden de las beggiatoales o del genero vitreoscilla como ingrediente activo de un medicamento destinado a estimular la inmunidad no especifica.
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
ATE189228T1 (de) Peptide mit zyklischen hauptketten, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ES2052815T3 (es) Derivados de aminoacido.
ES2106360T3 (es) Formulaciones farmaceuticas de aerosol que contienen dipropionato de beclometasona.
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
ES2065929T3 (es) Nuevos derivados de estilbeno, fabricacion y uso de los mismos como medicamentos.
ES2160163T3 (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
ES2165360T3 (es) Cicloalquenos y cicloalcanos 1,3-sustituidos como agentes del sistema nervioso central.
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
ES2134787T3 (es) Derivados de poliaspartamida como agentes de adsorcion para acidos biliares, derivados de poliaspartamida cargados con acidos biliares, y procedimiento para su preparacion, asi como su utilizacion como medicamentos.
ATE173627T1 (de) Medizinische zusammensetzung
ES8700232A1 (es) Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES2138613T3 (es) Derivado de espirooxatiolano-quinuclidina para el tratamiento del sindrome de sjoegren.
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
ES2077514B1 (es) Composicion farmaceutica topica para el tratamiento de alergias respiratorias.
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
FR2680172B1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
ES2125945T3 (es) Derivados antimicrobianos del carbapenemo, su preparacion y su utilizacion terapeutica.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
ES2066914T3 (es) Factores a1, a2, a3 y h del antibiotico ge 2270.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19931117

Kind code of ref document: B1

Effective date: 19931117